All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0986 | Anti-HARS2 (CBFYH-0703) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Dog, Primate | CBFYH-0703 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0987 | Anti-HARS2 (CBFYH-0704) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0704 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0988 | Anti-HARS2 (CBFYH-0705) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0705 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0989 | Anti-HARS2 (CBFYH-0706) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0706 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0990 | Anti-HARS2 (CBFYH-0707) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0707 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0991 | Anti-HARS2 (CBFYH-0708) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Dog, Monkey | CBFYH-0708 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4239 | Anti-HARS2 (CBFYH-0703) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Dog, Primate | CBFYH-0703 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4240 | Anti-HARS2 (CBFYH-0704) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0704 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4241 | Anti-HARS2 (CBFYH-0705) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0705 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4242 | Anti-HARS2 (CBFYH-0706) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0706 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4243 | Anti-HARS2 (CBFYH-0707) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0707 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4244 | Anti-HARS2 (CBFYH-0708) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Dog, Monkey | CBFYH-0708 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION